A 2016 systematic review on the prevalence of CRP (3) found that 38% of 32,261 patients across 52 studies reported at least moderate CRP, while a 2009 European survey study (4) indicated that of 5,084 adults with cancer, 56% reported moderate to severe CRP. The gene discussed is CRP; the disease is cancer.